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Summary 
To investigate the role of the presumed DNA mismatch 
repair (MMR) gene Msh2 in genome stability and tu- 
morigenesis, we have generated cells and mice that 
are deficient for the gene. Msh2-deficient cells have 
lost mismatch binding and have acquired microsatel- 
lite instability, a mutator phenotype, and tolerance to 
methylating agents. Moreover, in these cells, homolo- 
gous recombination has lost dependence on complete 
identity between interacting DNA sequences, suggest- 
ing that Msh2 is involved in safeguarding the genome 
from promiscuous recombination. Msh2-deficient 
mice display no major abnormalities, but a significant 
fraction develops lymphomas at an early age. Thus, 
Msh2 is involved in MMR, controlling several aspects 
of genome stability; loss of MMR-controlled genome 
stability predisposes to cancer. 
Introduction 
Cancer is the endpoint of an evolutionary process in which 
normal cells acquire full malignancy by cumulative genetic 
or epigenetic alterations, each conferring proliferative, in- 
vasive, or metastatic potential to the cell. In colorectal can- 
cer, at least six independent transforming mutations in 
oncogenes or tumor suppressor genes are required for a 
cell to develop into a fully malignant umor (reviewed by 
Vogelstein and Kinzler, 1993). This evolutionary process 
might be dramatically accelerated by the early loss of 
systems that safeguard genome stability, resulting in an 
increased rate of mutagenesis and chromosomal re- 
arrangements (Hartwell, 1992; Loeb, 1994). In support of 
this hypothesis, a number of hereditary cancer predisposi- 
tion syndromes are attributed to defects in DNA repair. 
Two of these are hereditary nonpolyposis colorectal can- 
cer (HNPCC) and Muir-Torre syndrome, which are char- 
acterized by the development of tumors of the proximal 
colon at early age. Cancers of other parts of the gastroin- 
testinal tract and of the genitourinary tract are also often 
found (Lynch et al., 1993). Muir-Torre patients are, in addi- 
tion, prone to cancers of the sebaceous glands and the 
skin (Cohen et al., 1991). Individuals affected by one of 
these syndromes have most likely inherited a mutant allele 
of either one of four mismatch repair (MMR)-related genes, 
MSH2, MLFI1, PMS1, or PMS2 (Leach et al., 1993; Bronner 
et al., 1994; Kolodner et al., 1994, 1995; Liu et al., 1994; 
Nicolaides et al., 1994; Papadopoulos et al., 1994; re- 
viewed by Jiricny, 1994; reviewed by Modrich, 1994). In 
tumors of these patients, MMR is lost, presumably through 
inactivation or loss of the wild-type allele (Leach et al., 
1993; Nicolaides et al., 1994; Papadopoulos et al., 1994; 
Hemminki et al., 1994). The mechanisms of loss of MMR, 
the cause of the apparent tissue specificity of tumorigen- 
esis, and the role of loss of MMR in the evolution of a 
normal cell to fully malignant tumors are still obscure. 
Moreover, recent data suggest that MMR is frequently lost 
in many types of sporadic tumors (Han et al., 1993; Parsons 
et al., 1993; Risinger et al., 1993; Chong et al., 1994; Miro- 
nov et al., 1994; Orth et al., 1994; Shibata et al., 1994; 
Suzuki et al., 1994; U mar et al., 1994b; Wada et al., 1994; 
Wooster et al., 1994; Liu et al., 1995). This supports the 
notion that loss of MMR may play a general role in tumor 
evolution. 
The best-studied MMR system with respect to both ge- 
netics and biochemistry is the mutSL pathway of Esche- 
richia coli (reviewed by Modrich, 1991). Central in this 
pathway is the protein encoded by the mutS gene, which 
binds to base mispairs and to loops of up to four unpaired 
nucleotides. After binding to the heteroduplex, the MutS- 
DNA complex is bound by the mutL gene product, trig- 
gering excision of a tract of single-stranded DNA of up to 
several kilobases that contains the mismatched nucleo- 
tide(s). The repair process is completed by resynthesis of 
the excised DNA strand and ligation of the remaining nick. 
MMR in E. coli is responsible for maintaining genome in- 
tegrity in at least two ways: by recognizing and repairing 
mispaired and extrahelical nucleotides that occur by, re- 
spectively, misincorporation and slippage during replica- 
tion and by recognizing mismatches occurring in recombi- 
nation intermediates between homologous but diverged 
sequences, leading to abortion of recombination. Conse- 
quently, E. coli strains deficient for either mutS or mutL 
have a pleiotropic phenotype: an increased mutation rate, 
including destabilization of simple-sequence repeats (also 
called microsatellites; the replication error-positive [RER ÷] 
phenotype) and promiscuity in inter- and intragenomic re- 
combination (the recombinator phenotype; Rayssiguier et 
al., 1989; Petit et al., 1991). 
In many respects, the biochemistry of MMR systems in 
eukaryotes resembles that of the mutSL system (Holmes 
et al., 1990; Varlet et al., 1990; Thomas et al., 1991; Fang 
and Modrich, 1993). Homologs of both mutS and mutL 
were found in eukaryotes. Based on mismatch binding in 
vitro and on the mutator and recombinator phenotypes of 
Saccharomyces cerevisiae mutants, the protein encoded 
by the yeast MSH2 gene (Reenan and Kolodner, 1992a) 
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Figure 1. Targeted Disruption of the Mouse 
Msh2 Gene 
(A) (Top) Schematic diagram of the mouse 
MSH2 protein. The parts marked ATP binding 
and HTH indicate putative ATPase and helix- 
turn-helix domains, respectively (Varlet et al., 
1994). The position at which the protein is dis- 
rupted by insertion of the hyg marker is indi- 
cated. (Bottom) The genomic Msh2 locus; indi- 
cated below is the targeting construct carrying 
the hyg marker inserted into a unique SnaBI site within an exon sequence of Msh2. The positions of the external probes used for detection of 
targeting events are indicated. 
(B) The Msh2 locus in Msh2 +~÷ cell line wt-2, Msh2 +j- cell line sMsh2-55, and Msh2 ÷ cell line dMsh2-9. Genomic DNA of these cell lines was 
digested with EcoRI and analyzed by Southern blot hybridization using probe 1, as shown in (A). Arrowheads indicate the positions of the wild-type 
(wt) (20 kb) and disrupted (ko) (7.5 kb) alleles. 
seems to be the functional homolog of MutS (Reenan and 
Kolodner, 1992b; Miret et al., 1993; Alani et al., 1995). In 
higher eukaryotes (Xenopus laevis, mouse, and human), 
homologs of the yeast MSH2 gene have recently been 
identified, based on either sequence homology, direct se- 
quencing of the major mismatch-binding protein, or posi- 
tional cloning (Fishel et al., 1993; Leach et al., 1993; Pa- 
Iombo et al., 1994; Varlet et al., 1994). An apparent 
difference between MutS and MSH2 is the binding of the 
eukaryotic protein, when overproduced and purified from 
E. coli or yeast, to stretches of up to 14 extrahelical nucleo- 
tides (so-called insertion/deletion-type loops [IDLs]) in vitro 
(Fishel et al., 1994b; Alani et al., 1995), suggestive of a 
role for MSH2 in the repair of these loops (Umar et al., 
1994a). Eukaryotic homologs of the mutL gene, MLH1, 
PMS1, and PMS2, have been analyzed in yeast (Kramer et 
al., 1989a, 1989b; Strand et al., 1993; Prolla et al., 1994a, 
1994b) and human (Li and Modrich, 1995) cells. 
The precise role of these mutS and mutL homologs in 
MMR and the role of MMR in the maintenance ofgenome 
stability in mammalian cells remain to be established. In 
addition, the causative role of MMR in cellular sensitivity 
to simple methylating agents, as was suggested by the 
loss of MMR after selection of cells for tolerance to these 
agents (Branch et al., 1993; Kat et al., 1993) and by the 
methylation tolerance of a MMR-deficient umor cell line 
(Koi et al., 1994), remains to be explored. 
To investigate the involvement of MSH2 in mammalian 
MMR and the roles of MMR in maintaining enome stabil- 
ity, we have generated mouse embryonic stem (ES) cell 
lines that lack both copies of the Msh2 gene. We show 
that Msh2-deficient cells lack binding to some specific mis- 
matches, have acquired a mutator phenotype, and are 
tolerant to simple methylating agents. Moreover, these 
cells have lost the barrier to recombination between ho- 
mologous but diverged sequences. Taken together, these 
results suggest that MMR is essential for the preservation 
of multiple aspects of genome stability in mammalian cells. 
To study the effect of MMR deficiency on the etiology 
and evolution of cancer, we generated mice lacking one 
or both copies of the Msh2 gene in part or all of their cells. 
Although heterozygous mice, a model for H N PCC, remain 
healthy to at least 8 months of age, a significant fraction 
of both chimeric and fully homozygous Msh2 knockout 
mice succumbs to lymphomas. These results provide evil 
dence that loss of MMR-controlled genome stability can 
accelerate the development of cancer. 
Results 
Targeted Disruption of the Msh2 Gene 
in Mouse ES Cells 
Heterozygous ES cell lines sMsh2-42 and sMsh2-55, car- 
rying a hygromycin (hyg) resistance gene inserted be- 
tween codons 588 and 589 of one allele of the Msh2 gene, 
were generated by gene targeting using the construct 
shown in Figure 1A. Cell line dMsh2-9, carrying the hyg 
marker in both alleles of the Msh2 gene, was obtained by 
selecting cell line sMsh2-55 for duplication of the chromo- 
some carrying the targeted Msh2 allele at an elevated hy- 
gromycin B concentration, a method that was previously 
shown to be effective using the neomycin (neo) resistance 
marker (Mortensen et al., 1992). Targeting events were 
detected by Southern blot analysis, using probes flanking 
both sides of the targeting construct (Figure 1A). An exam- 
ple of such a Southern blot, demonstrating the status of 
the Msh2 alleles in cell lines wt-2 (a control cell line with 
the targeting construct integrated by nonhomologous re- 
combination), sMsh2-55, and dMsh2-9, is shown in Figure 
1 B. Diploidy of cell lines sMsh2-55 and dMsh2-9 was veri- 
fied by karyotyping (data not shown). 
The hyg marker was inserted, in the antisense orienta- 
tion, N-terminally of the putative ATP-binding site (Figure 
1A) in a region where (in the human gene) truncations 
were found in many HNPCC tumors (Liu et al., 1994). 
Moreover, no Msh2 transcript could be detected in ES 
cell line dMsh2-9 by Northern blotting (data not shown), 
indicating that the hyg marker strongly suppressed Msh2 
expression. The genotype of ES cell line dMsh2-9 will 
therefore be indicated by Msh2 -~-. 
Mismatch Binding in Msh2 -~- Cells 
Two different mismatch-binding activities have been de- 
termined in mammalian cell extracts through the use of 
gel retardation assays: one activity recognizes G-T mis- 
matches (Jiricny et al., 1988; Stephenson and Karran, 
1989; Griffin and Karran, 1993), an extrahelical TG dinu- 
cleotide (Aquilina et al., 1994) representing an interme- 
diate in replicational slippage of a microsatellite, and, 
weakly, G .A, G-G, A. C, and G. U mismatches (Stephen- 
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Figure 2. Mismatch-BindingActivityinWild-TypeandMsh2-Deficient 
Cells 
Binding activity in extracts of Msh2 +~+ cell line wt-2 and Msh2 ~ cell ine 
dMsh2-9 to double-stranded oligonucleotides containing a mismatch 
(G.T, G .A, G.G, or A.C), an extrahelical dinucleotide (Extrahelical 
TG), or an extrahelica114 nt loop (LOOP14) and a homoduplex was 
assessed using a gel retardation assay. Sequences of the oligonucleo- 
tides are given in Experimental Procedures. Arrowheads indicate the 
positions of mismatch-specific complexes. E2F indicates binding to 
an oligonucleotide carrying an E2F site, which served as a positive 
control (Beijersbergen etal., 1995). 
son and Karran, 1989; Hughes and Jiricny, 1992), while, 
in one cell line, an independent activity recognizes A.C 
mismatches and also pyrimidine, pyrimidine mismatches 
(Stephenson and Karran, 1989). Based on protein se- 
quencing, the purified G-T-binding activity was shown to 
contain the MSH2 protein (Palombo et al., 1994). To char- 
acterize the mismatch binding properties of the Msh2 -~- 
ES cell line, we have performed gel retardation assays 
using cell extracts of wild-type ES cell line wt-2 and Msh2- 
deficient line dMsh2-9. Extracts were incubated with radio- 
labeled 38-mer double-stranded oligonucleotides contain- 
ing either a mismatch, an extrahelical dinucleotide, or a 
14 nt IDL, followed by electrophoresis on a nondenaturing 
polyacrylamide gel. Results of these experiments, as 
shown in Figure 2, clearly demonstrate binding activity 
in wild-type cell extracts to a G-T mismatch and to an 
extrahelical TG dinucleotide. Binding to both oligonucleo- 
tides was entirely absent in the extract of the Msh2 -~- ES 
cell line, demonstrating the involvement of the MSH2 pro- 
tein in this binding activity. As shown before (Hughes and 
Jiricny, 1992), binding was abolished by the inclusion of 
ATP in the binding reaction (data not shown). We were 
unable to detect specific binding to G.A, G.G, or A.C 
mismatches under the conditions used in wild-type or mu- 
tant cell extracts. In addition, no MSH2-dependent binding 
to a 14 nt IDL was observed (Figure 2). 
Msh2 -~- Cells Have a Mutator  Phenotype  
The Msh2 -j- cell line was indistinguishable from the wild- 
type cell line wt-2 and the parental heterozygous cell line 
sMsh2-55 with respect to growth and plating efficiency 
(data not shown), To address the role of MSH2 in MMR, 
we determined the stability of two microsatellite markers 
in Msh2 -~- cell line dMsh2-9 and Msh2 +1÷ line wt-2. For 
this purpose, 24 subclones were derived of each cell line, 
which had undergone approximately 20 cell divisions 
since its generation. Chromosomal DNA, isolated from 
each expanded subclone, was subjected to the poly- 
merase chain reaction (PCR) using two end-labeled 
primer pairs (D7Mit17 and D14Mit15; Dietrich et al., 1994). 
Whereas none of the wt-2 sublines showed any alteration 
in microsatellite length, clear length alterations in many 
dMsh2-9 sublines were seen for both microsatellites (8 
out of 24 for marker D7Mit17 and 6 out of 24 for marker 
D14Mit15; Figure 3). This observation strongly suggests 
that the MSH2 protein is involved in the repair of slipped 
replication intermediates. The microsatellite-slippage rate 
was estimated to be 10 -2 to 10 -3 per generation. 
We subsequently investigated the effect of loss of the 
Msh2 gene on the mutation frequency of a functional gene. 
To this purpose, 6 x 106 cells of cell lines wt-2 and 
dMsh2-9 were plated in the presence of 6-thioguanine to 
select for cells that have lost activity of the X-linked Hprt 
gene by mutation. Whereas no 6-thioguanine-resistant 
colonies were seen in the wt-2 culture, 188 resistant colo- 
nies were present in the dMsh2-9 culture. This result ex- 
tends the mutator phenotype of Msh2 -~- cells to functional 
genes. 
Msh2 -j- Cel ls Are  Tolerant  to 
N-Methy I -N ' -N i t ro -N-Ni t rosoguanid ine  
MMR was suggested to mediate hypersensitivity oagents 
that methylate G residues at the 06 position (O6-meG). It 
is believed that MMR recognizes the OS-meG-T mispair 
that occurs after erroneous incorporation of a thymidine 
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Figure 3. Microsatellite Stability in Wild-Type 
and Msh2-Deficient Cells 
Genomic DNA of 24 subclones derived from 
Msh2 +1+ cell line wt-2 and Msh2 -~- cell line 
dMsh2-9 was amplified by PCR using primer 
sets DTMit17 and D14Mit15. Arrowheads indi- 
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Figure 4. ToleranceofMsh2-DeficientCeUstotheSimpleMethylating 
Agent MNNG 
ES cell lines wt-2 (Msh2÷~+), sMsh2-55 (Msh2+~-), and dMsh2-9 
(Msh2 -~-) were exposed to increasing amounts of MNNG for 1 hr in 
the presence of O6-benzylguanine. After 4 days of incubation, cells 
were trypsinized and counted. 
et al., 1994). This is supposedly followed by excision and 
repair synthesis, again incorporating thymidine opposite 
to O6-meG, triggering a new round of MMR. The net result 
of this cycling between excision and resynthesis will be the 
presence of single-stranded regions at the site of O6-meG 
residues that will lead to double-stranded gaps when repli- 
cated during S phase, resulting in cell death (reviewed by 
Karran and Bignami, 1992, 1994). It is predicted that loss 
of MMRwill prevent his process, thus conferring tolerance 
to simple methylating agents. To test this hypothesis di- 
rectly, we determ ined survival of Msh2 -~- cell line dMsh2-9, 
Msh +~- cell line sMsh2-21, and wild-type cell line wt-2 after 
exposure to a range of concentrations of N-m ethyI-N'-nitro- 
N-nitrosoguanidine (MNNG). In the growth medium, 06- 
benzylguanine was included to inhibit endogenous meth- 
yltransferase activity competitively that might otherwise 
remove the methyl groups added by MNNG (Dolan et al., 
1990). Figure 4 shows that the LD~o for MNNG was in- 
creased 20-fold in the Msh2 -~- cell line compared with the 
heterozygous and wild-type cell lines, directly proving the 
involvement of MSH2 in determining cellular sensitivity 
to MNNG. Heterozygous cell line sMsh2-21 displayed no 
increased tolerance to MNNG. 
Loss of Suppression of Recombination between 
Diverged Sequences in Msh2 -~- Cells 
In E. coil (Shen and Huang, 1986), Drosophila (Nassif and 
Engels, 1993), and mammalian cells (Waldman and 
Liskay, 1988; te Riele et al., 1992), the efficiency of recom- 
bination between homologous DNA stretches is highly de- 
pendent on their sequence identity. We have previously 
demonstrated that in a gene targeting assay, homologous 
recombination at the retinoblastoma (Rb) locus in ES cells, 
derived from mouse strain 129, was 50-fold more efficient 
with a 129-derived targeting construct than with a con- 
struct derived from a nonisogenic (BALB/c) mouse strain 
(te Riele et al., 1992; Table 1). This construct contained 
0.6% base sequence divergence with respect to the iso- 
genic 129 construct. To provide additional evidence that 
suppression of recombination was solely dependent on 
the polymorphisms between the endogenous locus and 
the targeting DNA, we performed the inverse experiment, 
i.e., targeting of a BALB/c-derived ES cell line with the 
129- and BALB/c-derived constructs. This experiment 
yielded the inverse result, i.e., a higher targeting efficiency 
with the BALB/c targeting construct han with the noniso- 
genic 129 targeting construct (Table 1). To investigate 
whether MMR is responsible for this antirecombination 
effect, we have repeated the Rb targeting experiment in 
the (129-derived) ES cell line dMsh2-9. We found that in 
the Msh2 -j- cell line, homologous recombination at the Rb 
locus with the nonisogenic construct was as efficient as 
with the isogenic construct (Table 1). This experiment 
demonstrates that MSH2 is involved in preventing homolo- 
gous recombination between diverged DNA sequences. 
Msh2-Deficient Mice Are Viable but Predisposed 
to Tumorigenesis 
To study the effect of MMR deficiency on the development 
of cancer, Msh2 +~- ES cell lines sMsh2-55 and sMsh2-42 
and Msh2 -~- ES cell line dMsh2-9 were used to generate 
chimeric mice. Both the Msh2 single and double knockout 
ES cells gave rise to healthy animals with coat-color chime- 
rism of 20%-70%. This result suggests that MMR defi- 
ciency did not alter the capacity of the ES cells to compete 
with wild-type cells in chimeric development. 
Msh2 ÷~- chimeras were found to transmit he mutant al- 
lele through the germline, resulting in Msh2 heterozygous 
F1 mice. These mice, which may serve as a model for 
HNPCC, were healthy up to at least 8 months of age 
(Table 2). 
Intercrossing of Msh2 ÷~- mice resulted in Msh2 -~- mice 
according to a normal Mendelian distribution; they were 
healthy at birth and fertile. However, 30% of the Msh2 -~- 
mice developed metastasizing lymphomas of T cell origin, 
with a peak at 2 months of age (Table 2). In addition, one 
mouse suffered from generalized histiocytic sarcoma at 
Table 1. Homologous Recombination Has Lost Dependence on Sequence Identity in Msh2-Deficient ES Cells 
Homologous Recombination versus Total Number of 
G418 R Colonies Isogenic versus 
ES Cells With 129Rb-neo (%) With B/cRb-neo (%) Nonisogenic 
BALB/c (Msh2 ÷~÷) 1 of 68 (1.5) 16 of 72 (22) 15x 
129/OLA (Msh2 ÷~*) 33 of 94 (35) 1 of 144 (0.7) 50x 
129/OLA (Msh2 -~-) 42 of 185 (23) 47 of 184 (26) 0.gx 
129Rb-neo and B/cRb-neo are Rb targeting constructs, prepared from the 129 and BALB/c strains of mice, respectively, With 0.6% sequence 
divergency. Targeting frequencies in 129/OLA (Msh2 ÷~÷) ES cells are derived from te Riele et al. (1992). 
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Table 2. Phenotypes of Msh2 Mutant Mice 
Tumor Incidence 
Genotype Age (Months) Condition atBirth Type Frequency ~ Age (Months) 
Msh2 ÷~- 8 Healthy 0 of 110 
Msh2÷~÷::Msh2-~- b 6 Healthy Lymphoma 1 of 24 2 
Msh2 -~- 4-5 Healthy Lymphoma 6 of 19 2-4 
Histiocytic sarcoma 1 of 19 3.5 
Number of mice carrying a tumor per total number in the experiment. 
b Chimeras consisting of wild-type and Msh2 -j- cells. 
3.5 months of age. Extensive histological analyses of 
these mice did not reveal any other abnormality. Also, 
healthy Msh2 + mice sacrificed at 2 months of age were 
histologically normal and had normal B cell and T cell 
populations as evidenced by fluorescence-activated cell 
sorting (FACS) analysis. 
Discussion 
Lack of Mismatch Binding in Msh2 + Cell Extracts 
Whereas wild-type cell extracts display efficient binding 
to both a G.T mismatch as well as to an extrahelical TG 
dinucleotide, extracts of the ES cell line dMsh2-9 lack this 
binding (Figure 2), suggesting that the MSH2 protein is 
essential for binding to these heteroduplexes. We were 
unable to detect specific binding activity to other mis- 
matches under the conditions used. This result is compati- 
ble with binding studies by others that demonstrate that 
binding to a G .T mismatch is stronger than to other mis- 
matches (Stephenson and Karran, 1989; Hughes and Ji- 
ricny, 1992), whereas the independent A. C binding activ- 
ity is apparently cell-type specific (Jiricny et al., 1988; 
Stephenson and Karran, 1989). The methylation-tolerant 
cell lines clone B and RajiF12 were also found to lack 
binding both to a G .T mismatch (Branch et al., 1993; Grif- 
fin et al., 1994) and to an extrahelical TG dinucleotide 
(Aquilina et al., 1994). Binding to an A.C mismatch was 
unaffected (Branch et al., 1993). Therefore, these cell lines 
may have lost the Msh2 gene. Purified human MSH2, over- 
produced in E. coil, and purified yeast MSH2 were shown 
to bind to G. T mismatches (Fishel et al., 1994a; Alani et 
al., 1995), but also strongly to IDLs of up to 14 nt (Fishel 
et al., 1994b; Alani et al., 1995). Surprisingly, we could 
not detect MSH2-dependent binding to a 14 nucleotide IDL 
in ES cell extracts. We are unable to explain this apparent 
discrepancy. In contrast with the binding that we observed 
in ES cell extracts and that of the GTBP protein, the 
MSH2-containing G.T mismatch-binding protein fraction 
purified from HeLa cells (Hughes and Jiricny, 1992; Pa- 
Iombo et al., 1994), the binding capacity of the purified 
MSH2 proteins was not abolished by ATP (Fishel et al., 
1994b; Alani et al., 1995). This suggests that the purified 
MSH2 proteins behave differently from the naturally pro- 
duced protein. The finding that in Msh2 + cells length 
shifts in microsatellites were never larger than 4 nt (repre- 
senting two CA dinucleotides; Figure 3) suggests that bind- 
ing activity of MSH2 to extrahelical loops longer than 4 nt 
is not required to maintain microsatellite stability. We are 
currently initiating in vitro repair assays using wild-type 
and Msh2 + cell extracts to elucidate this point further. 
Mutator Phenotype of Msh2.Def ic ient  Cells 
Cell line dMsh2-9 had acquired microsatellite instability 
(the RER ÷ phenotype), indicating failure to repair slipped 
replication intermediates. The frequency of microsatellite 
instability was similar to that of some RER + tumor cell lines 
(Parsons et al., 1993; Bhattacharyya et al., 1994). The 
mutator phenotype of these cells also affects functional 
genes as evidenced by the rate of Hprt  deficiency in a 
dMsh2-9 culture that was increased from undetectable 
(i.e., lower than 1.6 x 10 -7) for wild-type cells to 3 x 10 -5. 
This frequency is in agreement with that found in some 
RER ÷ tumor cell lines (Bhattacharyya et al., 1994; Shibata 
et al., 1994; Eshleman et al., 1995), although cell lines 
that have been selected for MMR deficiency using a meth- 
ylating agent tend to have somewhat lower mutation fre- 
quencies (Goldmacher et al., 1986; Branch et al., 1993; 
Kat et al., 1993; Aquilina et al., 1994). Growth rate and 
plating efficiency of Msh2-def ic ient ,  heterozygous, and 
wild-type cells were indistinguishable, suggesting that the 
mutator phenotype does not interfere with viability of the 
cells. This is remarkable, since both were seriously af- 
fected in some cell lines that were selected for MMR defi- 
ciency using methylating agents (Goldmacher et al., 
1986). This suggests that in the latter cells, additional 
events may have taken place that interfere with cell viabil- 
ity. Based on the mutator phenotype of dMsh2-9 cells and 
on the binding studies described above, we conclude that 
MSH2 is involved in and essential for postreplica- 
tional MMR. 
Sensitivity to Simple Methylating Agents 
Is Mediated by MMR 
Sensitivity of cells to agents that methylate DNA at the 06 
position of G residues has been attributed to futile attempts 
of MMR to correct the resulting O6-meG • T basepairs (see 
Results). This hypothesis is supported by two observa- 
tions. First, prolonged selection of cells for tolerance to 
methylnitrosourea or MNNG frequently results in loss of 
MMR (Kat et al., 1993) and loss of G.T-binding activity 
(Branch et al., 1993; Griffin et al., 1994). Second, an RER ÷ 
tumor cell line was found to be tolerant to these agents, 
and sensitivity was restored by introduction of the chromo- 
some containing a wild-type allele of the defective MMR 
gene (Koi et al., 1994). Our finding that that Msh2-def ic ient  
cell line dMsh2-9 had acquired tolerance to MNNG pro- 
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vides direct evidence in support of this hypothesis. This 
finding may have important clinical implications. The tri- 
azene class of carcinostatic drugs probably derives its 
cytotoxic effect from methylation at the 06 position of G 
residues (Michejda et al., 1994). Whereas MMR-deficient 
tumors are supposedly tolerant to these drugs, they may 
elicit severe cytotoxity in normal tissues of the patient. In 
addition, the persistence of O6-meG • T mispairs in MMR- 
deficient umor cells might lead to increased G to A transi- 
tions (Aquilina et al., 1993), resulting in acceleration of 
tumor progression. Finally, the finding that simple methyl- 
ating agents select (or induce) MMR deficiency in cells 
has led to the hypothesis that this process is involved in 
determining the tisssue specificity of tumorigenesis in 
HNPCC patients, owing to the presence of such agents 
in the intestine (Karran and Bignami, 1994; Varlet et al., 
1994). 
MMR Edits Homologous Recombination 
in Mammalian Cells 
Previously, it has been shown that the presence of less 
than 1% nucleotide difference can strongly suppress ho- 
mologous recombination in mammalian cells (Waldman 
and Liskay, 1988; te Riele et al., 1992). Here, we have 
extended these results, and we have demonstrated that 
Msh2 -~- cells have lost this heterology-dependent sup- 
pression of recombination. Based on results obtained in 
E. coil (Worth et al., 1994), we have concluded that this 
function is probably mediated by the MSH2 protein by 
recognizing mismatches that occur during heteroduplex 
formation between two not perfectly complementary DNA 
strands. This may directly destabilize the heteroduplex 
or, alternatively, prevent elongation of strand exchange. 
Similar results have recently been obtained with MSH2- 
deficient yeast strains (Alani et al., 1994; Selva et al., 
1995), suggesting that this role of MMR is strongly pre- 
sewed during evolution. In E. coil, loss of MMR has been 
shown to result in a high frequency of inter- and intrachro- 
mosomal rearrangements owing to ectopic recombination 
between diverged sequences (Rayssiguier et al., 1989; 
Petit et al., 1991). More than the E. coil genome, mamma- 
lian genomes contain many repeated but diverged se- 
quences. Examples of these are gene families, SINE se- 
quences, LINE sequences, and pseudogenes (Brosius 
and Gould, 1992; Nowak, 1994). Ectopic recombination 
between these sequences would lead to genomic re- 
arrangements that may either be detrimental for cell viabil- 
ity due to loss of essential genomic information or, alterna- 
tively, lead to activation of oncogenes or inactivation of 
tumor suppressor genes (Bouffler et al., 1993). Homolo- 
gous recombination between identical DNA stretches 
should be allowed to proceed, however, to allow recombi- 
national repair of double strand breaks using the (identical) 
sister chromatid as sequence donor. For this reason, 
mechanisms counteracting homologous recombination 
when both recombining stretches contain divergencies, 
while permitting recombination to proceed when both 
stretches are identical, may be of great importance for the 
mammalian cell to enable repair without risking genome 
rearrangment. Based on the effect of Msh2 deficiency on 
gene targeting, it is likely that MMR plays this scrutinizing 
role. 
Our finding that Msh2 acts not only antimutagenically 
but also antirecombinogenically suggests that MMR defi- 
ciency may contribute to tumorigenesis by elevating the 
rate of both point mutations and chromosomal rearrange- 
ments. 
Role of Msh2 Deficiency in Tumorigenesis 
Msh2 deficiency did not interfere with mouse embryonic 
development and is compatible with adult life. This obser- 
vation substantiates the recent finding that some HNPCC 
patients seem largely MMR deficient in normal cells (Par- 
sons et al., 1995). A significant fraction of chimeric and 
pure Msh2 -~- mice developed metastasizing lymphomas. 
It is likely that the developing immune system in newborn 
mice, in which a high turnover of maturing T cells exists, 
offers a window in which MMR deficiency can strongly 
accelerate the accumulation of transforming events. 
The basal level of mutagenesis in the cell, estimated to 
be approximately 10 -1° per nucleotide per generation, is 
considered to be insufficient to sustain the m ultistep clonal 
outgrowth of cells in tumorigenesis (Loeb, 1994). There- 
fore, an increased mutation rate, such as caused by MMR 
deficiency, is likely to be obligatory to accelerate this pro- 
cess (Loeb, 1994). Our results suggest that a rapid cell 
expansion is required to unveil the effect of MMR defi- 
ciency on tumor development. Corroborating this notion, 
recent studies of microsatellite instability during cancer 
development show that loss of MMR probably does not 
occur as the initial step, but rather within an early tumor 
stage, such as an adenoma (Young et al,  1993; Aaltonen 
et al., 1994; Chong et al., 1994; Shibata et al., 1994; Wada 
et al., 1994), which, in HNPCC patients, has been found 
to evolve rapidly into carcinomas (Lynch et al., 1993; Jass 
et al., 1994). Moreover, two recent studies support the 
notion that enhanced mutagenesis due to MMR deficiency 
is responsible for tumor progression. In the first study, 
some RER + tumors had acquired frameshift mutations in 
the ~2-microglobulin gene within a CT repeat, indicative 
of unrepaired replication slippage and putatively leading 
to escape from immune surveillance (Bicknell et al., 1994); 
in the second study, in some RER ÷ colon carcinomas from 
HNPCC patients, p53 and APC were found to contain ei- 
ther frameshifts in repeated nucleotides or G to A transi- 
tions, indicative of the failure to repair slipped simple se- 
quence repeats and G- T mismatches, respectively (Lazar 
et al., 1994). 
In conclusion, our studies on Msh2 deficiency prove the 
involvement of Msh2 in MMR and show that MMR func- 
tions as a mechanism safeguarding the mammalian ge- 
nome against mutation by misincorporation and recombi- 
nation between diverged sequences. In addition, our 
results lend support to the hypothesis that MMR deficiency 
can strongly accelerate malignant ransformation of rap- 
idly expanding cell populations. 
Experimental Procedures 
Disruption of Msh2 in Mouse ES Cells 
Genomic Msh2 fragments were obtained by screening a 129/OLA- 
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derived genomic DNA library with a murine Msh2 cDNA probe (Varlet 
et al., 1994). The targeting construct was prepared by subcloning a 
12.5 kb BamHI fragment and inserting a hyg resistance gene (from 
PGK-hyg; te Riele et al., 1990) into the unique SnaBI site located 
within an exon sequence of Msh2. Cloning procedures were performed 
according to Sambrook et al. (1989). 
The targeting construct was separated from vector sequences by 
gel electrophoresis, purified by electroelution, and introduced into 129/ 
OLA-derived ES cell line E14 by electroporation as described pre- 
viously (te Riele et al., 1992). Electroporated cells were seeded onto 
gelatin-coated 10 cm dishes (107 cells per plate) and subjected to 
hygromycin B selection (150 ~g/ml) in BRL-conditioned medium 
(Hooper et al., 1987) the following day. After 10 days, individual hygro- 
mycin B-resistant colonies were randomly picked and expanded on 
mouse embryonic fibroblasts feeder layers. DNA was extracted from 
expanded colonies, digested with EcoRI, and analyzed by Southern 
blot hybridization using probes flanking both sides of the targeting 
construct (Figure 1A). Two cell lines were obtained out of 135 hygro- 
mycin B-resistant colonies showing bands diagnostic for correct inte- 
gration of the hyg marker between codons 588 and 589 of one copy 
of the Msh2 gene. These cell lines were designated sMsh2-42 and 
sMsh2-55. One cell line obtained from this experiment, designated 
wt-2, carrying a randomly integrated hyg gene, was used as an Msh2 *~+ 
control. 
To obtain an ES cell line carrying a disruption in both copies of 
Msh2, 106 cells of cell line sMsh2-55 were plated onto 10 cm plates 
and cultured in BRL-conditioned medium containing 1.0 or 1.5 mg/ml 
of hygromycin B. After 12 days of culturing in selective medium and 
7 days in nonselective medium, 24 colonies were obtained that had 
survived 1.5 mg/ml of hygromycin B. DNA was extracted from ex- 
panded colonies, digested with EcoRI, and analyzed by Southern blot 
hybridization. One cell line, designated dMsh2-9, carried two disrupted 
Msh2 alleles, had lost the wild-type copy, and contained the normal 
number of chromosomes. ES cell lines that had survived 1.0 mg/ml 
of hygromycin B still contained one disrupted and one wild-type Msh2 
copy. One of these Msh2 +j- lines was designated sMsh2-21 and used 
for several experiments. 
Generation of Msh2 Mutant Mice 
Chimeric mice were obtained by injecting 10-15 cells of ES cell lines 
sMsh2-55, sMsh2-42, and dMsh2-9 into C57BL/6 blastocysts. Male 
chimeras obtained with Msh2 +~- ES cells were crossed with wild-type 
129/OLA and FVB mice and found to transmit he mutated Msh2 allele 
through the germline. Homozygous Msh2 mutant mice were obtained 
by intercrossing F1 heterozygotes. 
Gel Shift Assay 
Preparation of cell extracts, annealing of oligonucleotides, binding 
of cell extracts to duplex oligonucleotides containing mismatched or 
extrahelical nucleotides, and nondenaturing polyacrylamide gel elec- 
trophoresis were performed essentially as described previously (Ste- 
phenson and Karran, 1989). However, gel electrophoresis was per- 
formed in TAE buffer rather than in TBE buffer. To obtain duplex 
oligonucleotides, we radiolabeled and annealed the oligonucleotide 
U (5'-GGGAAGCTGCCAGGCCCCAGTGTCAGCCTCCTATGCTC-3'; 
(sequences were derived from Aquilina et al., 1994) with any of the 
following unlabeled oligonucleotides: L-G.T, 5'-GAGCATAGGAGGC- 
TGACATTGGGGCCTGGCAGCTTCCC-3' (resulting in a G.T mis- 
match); L-G.A, 5'-GAGCATAGGAGGCTGACAATGGGGCCTGGCA- 
GCTTCCC-3' (resulting in a G.A mismatch); L-G.G, 5'-GAG- 
CATAGGAGGCTGACAGTGGGG CCTGGCAGCTTCCC-3' (resulting 
in a G.G mismatch); L-A. C, 5'-GAGCATAGGAGGCTGACACCGGGG- 
CCTGGCAGCTTCCC-3' (resulting in an A.C mismatch); L-TG, 5'- 
GAGCATAGGAGGCTGACACTGTGGGGCCTGGCAGCTTCCC-3' 
(resulting in an extrahelical TG dinucleotide); L-HOM, 5'-GAG- 
CATAGGAGGCTGACACTGGGGCCTGGCAGCTTCCC-3' (resulting 
in a homoduplex); L-LOOP14, 5'-GAGCATAGGAGGCTGACACATAC- 
GTGAGTACTCTGGGGCCTGGCAGCI-FCCC-3' (resulting in an IDL 
loop of 14 extrahelical nucleotides). In all assays, a 2-fold excess of 
unlabeled homoduplex competitor oligonucleotide was included. As 
a positive control, a duplex oligonucleotide containing the binding site 
for the E2F family of transcription factors was used (Beijersbergen et 
al., 1995). 
PCR Amplification of Microsatellites 
Subclones of ES cell lines dMsh2-9 and wt-2 were generated by seed- 
ing cells onto mouse embryonic fibroblasts feeder layers at a density 
of 103 cells per 10 cm 2, At that time, the ES cell lines were in culture 
for approximately 20 divisions since their generation; 24 colonies from 
each cell line were expanded. Chromosomal DNA was isolated and 
subjected to PCR using two end-labeled primer pairs (D14Mit15 and 
D7Mit17; Dietrich et al., 1994). Amplified products were electropho- 
resed on a denaturing polyacrylamide gel. 
Mutation Frequency 
Cells (6 x 106) of ES cell lines dMsh2-9 and wt-2 were plated onto 486 
cm 2 gelatin-coated tissue culture surface in BRL-conditioned medium. 
After 2 days, 6-thioguanine was added at a concentration of 10 pg/ 
ml. After 2 weeks, the number of resistant colonies was counted. 
Sensitivity to MNNG 
ES cell lines dMsh2-9, sMsh2-21, and wt-2 were seeded onto MEF 
feeder layers at a density of 103 cells per 4 cm 2, The following day, 
cells were exposed for 1 hr to MNNG ranging in concentration from 
0 to 36.45 pM in serum-free medium. After 4 days of incubation, cells 
were trypsinized, stained with trypan blue, and counted. During the 
whole procedure from 1 hr before exposure to MNNG, O6-ben -
zylguanine (20 ~M; provided by A. Pegg) was included in the medium to 
inhibit endogenous methyltransferase activity competively that might 
otherwise remove the methyl groups added by MNNG (Dolan et al., 
1990). 
Rb Targeting with Isogenic and Nonisogenic DNA 
Targeting and subsequent analysis of the Rb locus in a BALB/c-derived 
ES cell line (provided by S. Rastan) and the 129/OLA-derived ES cell 
line dMsh2-9 were performed essentially as described previously (te 
Riele et al., 1992). The targeting constructs 129Rb-neo (derived from 
the 129/OLA genome) and B/cRb-neo (derived from the BALB/c ge- 
home) carry an insertion of the pMCl-neo marker in exon 19 of the 
Rb gene and differ approximately 0.6% at the nucleotide level (te Riele 
et al., 1992). 
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Note Added in Proof 
At variance with the results of the accompanying paper (Baker, S. M., 
Bronner, C. E., Zhang, L., Plug, A. W., Robatzek, M., Warren, G., 
Elliott, E. A., Yu, J., Ashley, T., Arnheim, N., Flavell, R. A., and Liskay, 
R. M. [1995]. Male mice defective in the DNA mismatch repair gene 
PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82, 
this issue), Msh2 deficiency does not cause male sterility. This may 
suggest that another MutS-like protein serves as a partner of PMS2 
during meiotic recombination. 
